Sabby Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
2018
Q2
$89K Sell
2018
Q1
$680K Buy
2017
Q4
Hold
2017
Q3
Hold
2017
Q2
Hold
2017
Q1
Hold
2016
Q4
Sell
2016
Q3
$99K Sell
2016
Q2
$974K Sell
2016
Q1
$1.53M Sell
2015
Q4
$1.78M Buy
2015
Q1
Sell
2014
Q4
$55 Buy